Literature DB >> 28275643

A translational approach to clinical practice via stress-responsive glucocorticoid receptor signaling.

Mario F Juruena1, Bruno Agustini2, Anthony J Cleare2, Allan H Young2.   

Abstract

A recent article by Kwan and colleagues could elegantly demonstrate the necessary interaction between neuronal serotonin (5-HT) systems and the hypothalamic-pituitary-adrenal (HPA) axis through glucocorticoid receptors (GR), producing an adequate stress response, in this case, responding to hypoxia with an increase in hematopoietic stem and progenitor cells (HSPC). There is an intricate system connecting brain, body and mind and this exchange is only possible when all these systems-nervous, endocrine, and immune-have receptors on critical cells to receive information (via messenger molecules) from each of the other systems. There is evidence that the expression and function of GR in the hippocampus, mainly MR, is regulated by the stimulation of 5-HT receptors. Stressful stimuli increase 5-HT release and turnover in the hippocampus, and it seems reasonable to suggest that some of the changes in mineralocorticoid and GR expression may be mediated, in part at least, by the increase in 5-HT. Also serotonin and HPA axis dysfunctions have already been implicated in a variety of psychiatric disorders, especially depression. Early life stress (ELS) can have profound impact on these systems and can predispose subjects to a variety of adult metabolic and psychiatric conditions. It is important to analyze the mechanisms of this complex interaction and its subsequent programming effects on the stress systems, so that we can find new ways and targets for treatment of psychiatric disorders. Different areas of research on basic biological sciences are now being integrated and this approach will hopefully provide several new insights, new pharmacological targets and improve our global understanding of these highly debilitating chronic conditions, that we now call mental disorders.

Entities:  

Keywords:  Serotonin; early life stress (ELS); glucocorticoids (GC); hypothalamic–pituitary–adrenal (HPA) axis

Year:  2017        PMID: 28275643      PMCID: PMC5334557          DOI: 10.21037/sci.2017.02.01

Source DB:  PubMed          Journal:  Stem Cell Investig        ISSN: 2306-9759


  46 in total

Review 1.  The developmental role of serotonin: news from mouse molecular genetics.

Authors:  Patricia Gaspar; Olivier Cases; Luc Maroteaux
Journal:  Nat Rev Neurosci       Date:  2003-12       Impact factor: 34.870

2.  [A paradigm for understanding and treating psychiatric illness].

Authors:  Mario Francisco Juruena; Andrea H Marques; Andrea Feijo Mello; Marcelo Feijo Mello
Journal:  Braz J Psychiatry       Date:  2007-05       Impact factor: 2.697

Review 3.  Effects of stress throughout the lifespan on the brain, behaviour and cognition.

Authors:  Sonia J Lupien; Bruce S McEwen; Megan R Gunnar; Christine Heim
Journal:  Nat Rev Neurosci       Date:  2009-04-29       Impact factor: 34.870

4.  In utero and early-life conditions and adult health and disease.

Authors:  Philippe Grandjean; Jerrold J Heindel
Journal:  N Engl J Med       Date:  2008-10-02       Impact factor: 91.245

5.  Childhood maltreatment predicts unfavorable course of illness and treatment outcome in depression: a meta-analysis.

Authors:  Valentina Nanni; Rudolf Uher; Andrea Danese
Journal:  Am J Psychiatry       Date:  2012-02       Impact factor: 18.112

6.  Chronic overexpression of corticotropin-releasing factor from the central amygdala produces HPA axis hyperactivity and behavioral anxiety associated with gene-expression changes in the hippocampus and paraventricular nucleus of the hypothalamus.

Authors:  Elizabeth I Flandreau; Kerry J Ressler; Michael J Owens; Charles B Nemeroff
Journal:  Psychoneuroendocrinology       Date:  2011-05-26       Impact factor: 4.905

Review 7.  Stress in pregnancy and infant HPA axis function: conceptual and methodological issues relating to the use of salivary cortisol as an outcome measure.

Authors:  Kerry-Ann Egliston; Catherine McMahon; Marie-Paule Austin
Journal:  Psychoneuroendocrinology       Date:  2006-11-22       Impact factor: 4.905

Review 8.  Stressful life events and physical health.

Authors:  Dusica Lecic Tosevski; Milica Pejovic Milovancevic
Journal:  Curr Opin Psychiatry       Date:  2006-03       Impact factor: 4.741

9.  Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene.

Authors:  Avshalom Caspi; Karen Sugden; Terrie E Moffitt; Alan Taylor; Ian W Craig; HonaLee Harrington; Joseph McClay; Jonathan Mill; Judy Martin; Antony Braithwaite; Richie Poulton
Journal:  Science       Date:  2003-07-18       Impact factor: 47.728

10.  Prenatal SSRI alters the hormonal and behavioral responses to stress in female mice: Possible role for glucocorticoid resistance.

Authors:  Ronit Avitsur; Rachel Grinshpahet; Naama Goren; Ido Weinstein; Or Kirshenboim; Noa Chlebowski
Journal:  Horm Behav       Date:  2016-06-06       Impact factor: 3.587

View more
  4 in total

1.  Sensitive periods for psychosocial risk in childhood and adolescence and cardiometabolic outcomes in young adulthood.

Authors:  Jenalee R Doom; Kenia M Rivera; Estela Blanco; Raquel Burrows; Paulina Correa-Burrows; Patricia L East; Betsy Lozoff; Sheila Gahagan
Journal:  Dev Psychopathol       Date:  2020-12

Review 2.  Chinese Herbal Medicine for the Treatment of Depression: Effects on the Neuroendocrine-Immune Network.

Authors:  Chan Li; Bishan Huang; Yuan-Wei Zhang
Journal:  Pharmaceuticals (Basel)       Date:  2021-01-14

3.  The Volatile Oil of Zanthoxylum bungeanum Pericarp Improved the Hypothalamic-Pituitary-Adrenal Axis and Gut Microbiota to Attenuate Chronic Unpredictable Stress-Induced Anxiety Behavior in Rats.

Authors:  Daneng Wei; Yafei Zhao; Mengmeng Zhang; Lei Zhu; Li Wang; Xing Yuan; Chunjie Wu
Journal:  Drug Des Devel Ther       Date:  2021-02-22       Impact factor: 4.162

4.  Central Serous Chorioretinopathy and Blood Serotonin Concentrations.

Authors:  Takeshi Kimura; Takashi Araki; Yuki Komuku; Hisashi Iwami; Fumi Gomi
Journal:  J Clin Med       Date:  2021-02-03       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.